Intracardiac Undivided
Payments companies reported to CMS as associated with Intracardiac Undivided. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Intracardiac Undivided, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Intracardiac Undivided
These are the largest totals companies reported as associated with Intracardiac Undivided. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Edris Aman | Sacramento, CA | Cardiovascular Disease | $8,127.30 |
| Gagan Singh | Sacramento, CA | Cardiovascular Disease | $2,067.65 |
| Ryan Master | Shreveport, LA | Interventional Cardiology | $1,926.50 |
| Sudhakar Girotra | Farmington, NM | Interventional Cardiology | $1,739.96 |
| Milind Shah | Marshfield, WI | Interventional Cardiology | $1,739.95 |
| Jyothy Puthumana | Chicago, IL | Cardiovascular Disease | $1,577.32 |
| Perry Wengrofsky | Hackensack, NJ | Cardiovascular Disease | $1,437.18 |
| Ilie Barb | Gainesville, FL | Interventional Cardiology | $1,380.28 |
| Shire Beach | Stanford, CA | Cardiovascular Disease | $1,337.99 |
| Creighton Don | Seattle, WA | Interventional Cardiology | $1,169.79 |
Prescribed Intracardiac Undivided?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.